Cita APA (7th ed.)

Anthony, D., Sibson, N., Losey, P., Piani, D., & Leppert, D. (2009). Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis.

Cita Chicago (17th ed.)

Anthony, D., N. Sibson, P. Losey, D. Piani, i D. Leppert. Oral Fingolimod (FTY720) Therapy Reduces Blood Brain Barrier Breakdown, Microglial Activation, and Leukocyte Recruitment in a Focal DTH Model of Multiple Sclerosis. 2009.

Cita MLA (9th ed.)

Anthony, D., et al. Oral Fingolimod (FTY720) Therapy Reduces Blood Brain Barrier Breakdown, Microglial Activation, and Leukocyte Recruitment in a Focal DTH Model of Multiple Sclerosis. 2009.